ALAVERT ALLERGY is a Oral Tablet, Orally Disintegrating in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Loratadine.
| Product ID | 0573-2620_1ad9e626-55ca-4d43-b5ec-cc4d5bf19b07 |
| NDC | 0573-2620 |
| Product Type | Human Otc Drug |
| Proprietary Name | ALAVERT ALLERGY |
| Generic Name | Loratadine |
| Dosage Form | Tablet, Orally Disintegrating |
| Route of Administration | ORAL |
| Marketing Start Date | 2002-12-19 |
| Marketing Category | NDA / NDA |
| Application Number | NDA021375 |
| Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
| Substance Name | LORATADINE |
| Active Ingredient Strength | 10 mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2002-12-19 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA021375 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2002-12-19 |
| Marketing Category | NDA |
| Application Number | NDA021375 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2010-06-29 |
| Marketing End Date | 2011-08-17 |
| Marketing Category | NDA |
| Application Number | NDA021375 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2002-12-19 |
| Marketing Category | NDA |
| Application Number | NDA021375 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2002-12-19 |
| Marketing End Date | 2011-08-17 |
| Marketing Category | NDA |
| Application Number | NDA021375 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2002-12-19 |
| Marketing Category | NDA |
| Application Number | NDA021375 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2002-12-19 |
| Marketing Category | NDA |
| Application Number | NDA021375 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2002-12-19 |
| Marketing End Date | 2011-08-17 |
| Marketing Category | NDA |
| Application Number | NDA021375 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2002-12-19 |
| Marketing End Date | 2011-08-17 |
| Marketing Category | NDA |
| Application Number | NDA021375 |
| Product Type | HUMAN OTC DRUG |
| Marketing Start Date | 2002-12-19 |
| Marketing End Date | 2011-08-17 |
| Ingredient | Strength |
|---|---|
| LORATADINE | 10 mg/1 |
| SPL SET ID: | f45af3e4-5dd5-ea0a-c47c-8d68a1249158 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0573-2621 | ALAVERT ALLERGY | ALAVERT ALLERGY |
| 0573-2620 | ALAVERT ALLERGY | ALAVERT ALLERGY |
| 0363-1612 | allergy relief | Loratadine |
| 0113-7612 | Basic Care allergy relief | Loratadine |
| 0113-7500 | basic care childrens allergy relief | loratadine |
| 0113-7671 | Basic Care Childrens Allergy Relief | Loratadine |
| 0121-0849 | Childrens Loratadine | LORATADINE |
| 0363-2131 | Childrens Loratadine | Loratadine |
| 0363-4020 | CHILDRENS LORATADINE ODT | Loratadine |
| 0363-2092 | Childrens Wal-itin | Loratadine |
| 0363-2108 | Childrens Walitin | Loratadine |
| 0113-0612 | good sense allergy relief | Loratadine |
| 0113-1191 | good sense allergy relief | loratadine |
| 0113-1612 | good sense allergy relief | Loratadine |
| 0113-9755 | good sense allergy relief | loratadine |
| 0113-0671 | Good Sense childrens allergy relief | Loratadine |
| 0113-1019 | good sense childrens allergy relief | loratadine |
| 0113-1719 | good sense childrens allergy relief | Loratadine |
| 0363-0858 | Indoor Outdoor Allergy Relief | Loratadine |
| 0179-8317 | Loratadine | Loratadine |
| 0363-0522 | Loratadine | Loratadine |
| 0363-0527 | Loratadine | Loratadine |
| 0363-0752 | Loratadine | Loratadine |
| 0363-9603 | Loratadine | Loratadine |
| 0363-0699 | Wal itin | Loratadine |
| 0363-0754 | Wal-itin | LORATADINE |
| 0363-1686 | WAL-ITIN | LORATADINE |
| 0363-9150 | Wal-itin | Loratadine |
| 0363-2085 | Wal-itin Allergy Relief | Loratadine |